- Home
- PTGX vs LYFT Comparison
PTGX vs LYFT Comparison
Compare PTGX & LYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTGX | LYFT |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 5.2B |
| IPO Year | 2016 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PTGX | LYFT |
|---|---|---|
| Price | $121.88 | $14.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 29 |
| Target Price | ★ $108.23 | $20.07 |
| AVG Volume (30 Days) | 705.9K | ★ 13.2M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11250.00 |
| EPS | ★ 0.05 | 0.04 |
| Revenue | N/A | ★ $6,316,261,000.00 |
| Revenue This Year | $874.25 | $17.33 |
| Revenue Next Year | N/A | $12.29 |
| P/E Ratio | $2,455.60 | ★ $352.13 |
| Revenue Growth | N/A | ★ 9.16 |
| 52 Week Low | $49.86 | $12.46 |
| 52 Week High | $126.25 | $25.54 |
Technical Indicators
Market Signals| Indicator | PTGX | LYFT |
|---|---|---|
| Relative Strength Index (RSI) | 66.64 | 53.41 |
| Support Level | $94.48 | $12.85 |
| Resistance Level | N/A | $14.44 |
| Average True Range (ATR) | 4.67 | 0.59 |
| MACD | 1.54 | 0.03 |
| Stochastic Oscillator | 77.87 | 67.58 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
About LYFT Lyft Inc.
Lyft is the second-largest ride-sharing service provider in the US and Canada, connecting riders and drivers over the Lyft app. Incorporated in 2013 and public since 2019, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft has entered the bike- and scooter-share market to bring multimodal transportation options to users.